alexa Fei Ye | Mount Sinai School of Medicine

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Fei Ye

Fei Ye Fei Ye
Department of Pathology
Mount Sinai School of Medicine

Dr. Ye’s presently working in the department of Pathology, Mount Sinai School of Mediicne, USA. Research work had been focus on plant-derived agents and their anti-cancer activity and their molecular mechanism since 1995.

Research Interest

Dr. Ye’s research work had been focus on plant-derived agents and their anti-cancer activity and their molecular mechanism since 1995. One such drug, SBX, can inhibit NSCLC cell growth in vitro and in animals, and SBX directly targets the ERK pathway. More significantly, SBX is more potent and much tolerable than carboplatin, a most effective drug for NSCLC. Combination of SBX with carboplatin can synergistically increase the potency of their anticancer activity, probably acting cooperatively on different anti-proliferation mechanisms. Dr. Ye Also has a strong interest in drug and diagnostic marker discovery. In order for searching biomarkers and drugable targets for cancer diagnosis and treatment, Dr. Ye recently developed a novel Protein Pathway Array Technology ( The Pathway Array technology is an innovative proteomic assay that allows screen globally the changes in protein expression and phosphorylation. The focus of Protein Pathway Array is to determine the signaling networks that related to proliferation, apoptosis, angiogenesis, invasion and metastasis. Using this technology, Dr. Ye and her group identified several promising protein biomarkers for cancer diagnosis, molecular staging and prognosis.


Global Speakers in the subject

Global Experts in the subject


Multiple Literacies for Individuals who are Blind or with Visual Impairment: A Quantitative Comparison on Print, Braille, and Auditory Literacies
Ye Wang, Shariffa Khalid Qais Al-Said and Feifei Ye
Research Article: Int J Sch Cog Psychol 2017, 4: 193
DOI: 10.4172/2469-9837.1000193
Detection of Mitochondrial Mutations in Cancer by Next Generation Sequencing
Fei Ye, David C, Samuels and Yan Guo
Review Article: Next Generat Sequenc & Applic 2014,1: 102
DOI: 10.4172/2469-9853.1000102
Proteomic Approaches for Profiling Cancer Signaling Pathways
Fei Ye and David Y. Zhang
Editorial: J Mol Biomark Diagn 2012, 3: e104
DOI: 10.4172/2155-9929.1000e104
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version